$STAA 3 SEC Filings

Filed On	Filing
10 Feb 2026	Form 3: Wang Christopher Min Fang, Director Holds 3,257,130 shares of Common Stock, par value $0.01 per share
23 Jan 2026	Form 3: LeBuhn Richard T., Director Holds 21,268 shares of Common Stock
29 Apr 2025	Form 3: Silverman Lou, Director Holds 475 shares of Common Stock
18 Mar 2025	Form 3: Andrews Deborah J, Interim CFO Holds 8,586 shares of Common Stock
12 Mar 2024	Form 3: Butcher Arthur C, Director No securities owned
12 Mar 2024	Form 3: Jiang Wei, Director No securities owned
12 Dec 2023	Form 3: Sisitsky Nathaniel, General Counsel No securities owned
04 Dec 2023	Form 3: Zhou Lilian Yansheng, Director No securities owned
29 Mar 2023	Form 3: Michna Magda, Chief Clinical, Regulatory, No securities owned
29 Mar 2023	Form 3: Foust Warren, Chief Operating Officer No securities owned
05 Jul 2022	Form 3: Studholme Robert, Senior VP,Operations Holds 20,850 shares of Common Stock
17 Jun 2022	Form 3: Weisner Aimee S, Director No securities owned
26 Jan 2021	Form 3: Lin Elizabeth Yeu, Director No securities owned
26 Jan 2021	Form 3: Yu K Peony, Director No securities owned
12 Aug 2020	Form 3: Williams Patrick F., Chief Financial Officer No securities owned
03 Jun 2020	Form 3: Kliman Gilbert H, Director No securities owned
03 Jun 2020	Form 3: Frinzi Thomas G, Director No securities owned
10 Jul 2019	Form 3: Hansen Graydon C., Sr. VP, Global Operations Holds 15,000 shares of Common Stock
10 Jul 2019	Form 3: Hayashida Jon K., VP, Global Clinical, Medical Holds 21,323 shares of Common Stock
10 Jul 2019	Form 3: Barnes Scott D, Chief Medical Officer Holds 1,368 shares of Common Stock

Comments